Epigenetic Alterations in Bladder Cancer and Their Potential Clinical Implications

by Han Han, Erika M. Wolff, Gangning Liang
Published 2012-01-01

Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.

by Erika M Wolff, Hyang-Min Byun, Han F Han, Shikhar Sharma, Peter W Nichols, Kimberly D Siegmund, Allen S Yang, Peter A Jones, Gangning Liang
Published 2010-04-01

Study Protocol for the Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence (SISTER) study: a community engaged national randomized trial

by Ann Oluloro, Bryan Comstock, Sarah E Monsell, Maya Gross, Erika M Wolff, Liz Sage, Julianna Alson, Danielle C Lavallee, Bridgette Hempstead, Adrienne Moor, Ronit Katz, Kemi M Doll
Published 2024-02-01

Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high...

by John L. Gore, Erika M. Wolff, Bryan A. Comstock, Kristin M. Follmer, Michael G. Nash, Anirban Basu, Stephanie Chisolm, Douglas B. MacLean, Jenney R. Lee, Yair Lotan, Sima P. Porten, Gary D. Steinberg, Sam S. Chang, Scott M. Gilbert, Larry G. Kessler, Angela B. Smith, CISTO Collaborative
Published 2023-11-01